Advertisement
Letter| Volume 444, 120491, January 15, 2023

Download started.

Ok

Response to the letter of Gemignani et al.

Published:November 22, 2022DOI:https://doi.org/10.1016/j.jns.2022.120491
Response to the letter of Gemignani et al.
Previous ArticleLong-COVID phenotypes and small fiber neuropathy
Next ArticleImmune checkpoint inhibitor-related myositis and myocarditis with multiple myositis-specific/−associated antibodies
      we gladly respond to the letter from Gemignani et al. because this allows us to clarify some aspects of our findings on peripheral nervous system involvement during long-COVID.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Journal of the Neurological Sciences
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Register: Create an account
      Institutional Access: Sign in to ScienceDirect

      References

        • Hasrat N.H.
        • Kadhum H.J.
        • Hashim A.R.
        • Yakob Z.A.
        • Kadhim L.A.
        • Farid H.A.
        Neurographic evidence of inflammatory polyneuropathies in Peri-COVID-19 circumstances and their relationship with acute disease severity and inflammatory storm.
        Cureus. 2022 Mar 26; 14 (PMID: 35495005; PMCID: PMC9038593)e23517https://doi.org/10.7759/cureus.23517
        View in Article
        • Abrams R.M.C.
        • Simpson D.M.
        • Navis A.
        • Jette N.
        • Zhou L.
        • Shin S.C.
        Small fiber neuropathy associated with SARS-CoV-2 infection.
        Muscle Nerve. 2021; https://doi.org/10.1002/mus.27458
        View in Article
        • Sletten D.M.
        • Suarez G.A.
        • Low P.A.
        • Mandrekar J.
        • Singer W.
        COMPASS 31: a refined and abbreviated composite autonomic symptom score.
        Mayo Clin. Proc. 2012 Dec; 87 (PMID: 23218087; PMCID: PMC3541923): 1196-1201https://doi.org/10.1016/j.mayocp.2012.10.013
        View in Article
        • Klok F.A.
        • Boon G.J.A.M.
        • Barco S.
        • Endres M.
        • Geelhoed J.J.M.
        • Knauss S.
        • et al.
        The post-COVID-19 functional status (PCFS) scale: a tool to measure functional status over time after COVID-19.
        Eur. Respir. J. 2020; 1: 2001494
        View in Article

      Article info

      Publication history

      Published online: November 22, 2022
      Accepted: November 2, 2022
      Received: November 1, 2022

      Identification

      DOI: https://doi.org/10.1016/j.jns.2022.120491

      Copyright

      © 2022 Elsevier B.V. All rights reserved.

      ScienceDirect

      Access this article on ScienceDirect
      We use cookies to help provide and enhance our service and tailor content. To update your cookie settings, please visit the for this site.
      Copyright © 2023 Elsevier Inc. except certain content provided by third parties. The content on this site is intended for healthcare professionals.


      RELX